Live Breaking News & Updates on Arcinoma

Stay informed with the latest breaking news from Arcinoma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Arcinoma and stay connected to the pulse of your community

MASLD Plus HIV Ups Risk for CVD But Not Liver Disease

A large study reveals an increased risk for adverse cardiovascular events but not for liver disease progression in adults with MASLD disease and HIV infection.

California , United-states , Stanford-university , Palo-alto , American , Robertj-wong , Stanford-university-school-of-medicine , Division-of-gastroenterology , Stanford-university-school , American-journal , Hiv-infection

Pancreatic Fat Is the Main Driver for Pancreatic Diseases

The diffused presence of fat within the pancreas was the single most important driver for diseases of both the exocrine pancreas and endocrine pancreas, a recent study reported.

United-states , China , Yangzhou , Jiangsu , American , Xiaowu-dong , Pancreatic-center , Hospital-of-yangzhou-university , Yangzhou-university , Department-of-gastroenterology , Yangzhou-key-laboratory-of-pancreatic-disease , United-kingdom-biobank

Europe Recommends Three Cancer Drugs

The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.

Japan , Japanese , Eribulin-baxter , European-medicines-agency , European-union , Committee-for-medicinal-products-human-use , Medicinal-products , Human-use , Metastatic-colorectal , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma

How to Improve Radiotherapy Decisions in Endometrial Cancer

Radiotherapy decisions should be made using refined genomic guidance, as recommended by 2021 updated international guidelines, to better identify patients with molecularly aggressive disease.

United-states , Otilia-ciobanu , Key-changes , Often-does-undertreatment , Cancer-genome-atlas , Takeaways-for , Endometrial-carcinoma , Ndometrial-cancer , Arcinoma-of-the-endometrium , Ancer-of-the-endometrium , Radiation-therapy , Adiotherapy

Study identifies molecular pathway in liver cancer development

As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths.

Vienna , Wien , Austria , Erwin-wagner , Latifa-bakiri , Proceedings-of-the-national-academy-sciences , Meduni-vienna-clinical-institute-for-laboratory-medicine , University-of-vienna , Meduni-vienna , Clinical-institute , Laboratory-medicine , National-academy

Is the FDA Pausing More Cancer Trials? It's Hard to Tell

Clinical trial holds delay therapies getting to market and may be on the rise in oncology. But there's a lot the public doesn't know about how often these holds happen and why.

United-states , Boston , Massachusetts , Washington , American , Matthewe-brown , Joshua-sharfstein , Derek-scholes , Nelson-mullins , Julier-gralow , Johns-hopkins-bloomberg-school-of-public-health , American-society-of-clinical-oncology

Immunotherapy for Renal-Cell Carcinoma Saves Lives

A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.

United-kingdom , Boston , Massachusetts , United-states , Dana-farber-cancer-institute , Tonik-choueiri , European-medicines-agency , Harvard-medical-school , New-england-journal , Merck-sharp , Malignant-kidney-neoplasm-renal-cell-cancer-rcc-carcinoma-of-the

Few Cancer Survivors Meet ACS Nutrition, Exercise Guidelines

Only 4% of cancer survivors reported adhering to four key healthy lifestyle practices endorsed by the American Cancer Society.

United-states , Boston , Massachusetts , American , Carter-baughman , American-cancer-society , Behavioral-risk-factor-surveillance-system , Internal-medicine , Beth-israel-deaconess-medical-center , Cancer-survivor , Cancer , Alignant-neoplasia

Is Osimertinib Better Alone or With Chemotherapy in NSCLC?

A new study reveals that baseline EGFR mutations may be key to making the decision in the frontline setting.

Boston , Massachusetts , United-states , Illinois , University-of-chicago , Chicago , Dana-farber-cancer-institute , San-diego , California , American , Marina-garassino , Clinical-research-annual-meeting

Has Immunotherapy Found Its Place in Pancreatic Cancer?

A new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients with borderline resectable pancreatic cancer.

United-states , North-carolina , American , Zeva-wainberg , American-association-for-cancer-research , Duke-university-in-durham , University-of-california-los-angeles , California-los-angeles , American-association , Cancer-research , Annual-meeting